McGill and Jaeschke 2014) and to biomarkers that are amenable to measurement within biofluids that are easy to obtain in humans (e.g., blood and urine)
Lyophilized research vials: reconstitution determines everything Lyophilized vials add another variable: the reconstitution volume
Fulda S, Galluzzi L, Kroemer G
Case reports and small case series have described both tolerability and adverse outcomes in IBD patients receiving GLP-1 agonists, highlighting the need for individualized assessment
When a compound has no completed human trial, there is by definition no safety data in any subgroup no pregnancy data, no hepatic-impairment data, no interaction data with common metabolic or endocrine medications
By following these recommendations, the PWS community can establish a strong foundation of knowledge to ensure GLP-1 agonistsand potentially other emerging therapiesare used safely and effectively to improve lives